Could a liver scan spot hidden heart failure in minutes?

NCT ID NCT07449377

Recruiting now Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a device called FibroScan, which measures liver stiffness, can quickly diagnose acute heart failure in people who come to the emergency room with shortness of breath. Researchers will enroll 100 adults and compare the FibroScan results with standard tests. If it works, it could provide a faster, simpler way to diagnose heart failure in busy emergency settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FibroScan device (liver stiffness measurement)
What this could lead to: If successful, this could give emergency doctors a fast, non-invasive bedside tool to diagnose acute heart failure more accurately.
What could go wrong: This is a small, early-stage study (100 people) testing a device not originally designed for heart failure. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE HEART FAILURE (AHF)

Contacts and locations

Locations

Name: Emergency Department Hospital Pitié-Salpêtrière, APHP
RECRUITING

Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.